Characterizing the Effects of Calcium and Prebiotic Fiber on Human Gut Microbiota Composition and Function Using a Randomized Crossover Design-A Feasibility Study

Nutrients. 2021 Jun 4;13(6):1937. doi: 10.3390/nu13061937.

Abstract

Consumption of prebiotic inulin has been found to increase calcium absorption, which may protect against gut diseases such as colorectal cancer. This dietary relation may be modulated by compositional changes in the gut microbiota; however, no human study has addressed this hypothesis. We determined the feasibility of a randomized crossover trial to evaluate the effect of three interventions (combined calcium and inulin supplementation, calcium supplementation alone, and inulin supplementation alone) on the intestinal microbiota composition and function. We conducted a 16-week pilot study in 12 healthy adults who consumed the three interventions in a random sequence. Participants provided fecal and blood samples before and after each intervention. Each intervention period lasted four weeks and was flanked by one-week washout periods. 16S ribosomal RNA sequencing and quantification of short chain fatty acids (SCFA) was determined in fecal samples. Systemic lipopolysaccharide binding protein (LBP) was quantified in serum. Of the 12 individuals assigned to an intervention sequence, seven completed the study. Reasons for dropout included time (n = 3), gastrointestinal discomfort (n = 1), and moving (n = 1). Overall, participants reported positive attitudes towards the protocol (n = 9) but were unsatisfied by the practicalities of supplement consumption (44%) and experienced digestive discomfort (56%). We found no appreciable differences in microbial composition, SCFA concentration, nor LBP concentrations when comparing intervention periods. In conclusion, an intervention study using a randomized crossover design with calcium and a prebiotic fiber is feasible. Improvements of our study design include using a lower dose prebiotic fiber supplement and a larger sample size.

Keywords: calcium; crossover; dietary intervention; gut microbiota; prebiotic; short chain fatty acid.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Acute-Phase Proteins
  • Adolescent
  • Adult
  • Calcium, Dietary / administration & dosage
  • Calcium, Dietary / pharmacology*
  • Carrier Proteins / blood
  • Cross-Over Studies
  • Dietary Fiber / administration & dosage
  • Dietary Fiber / pharmacology*
  • Dietary Supplements
  • Drug Therapy, Combination
  • Fatty Acids, Volatile / analysis
  • Feasibility Studies
  • Feces / chemistry
  • Female
  • Gastrointestinal Microbiome / drug effects*
  • Gastrointestinal Microbiome / genetics
  • Haptoglobins
  • Humans
  • Insulin / administration & dosage
  • Insulin / pharmacology
  • Male
  • Membrane Glycoproteins / blood
  • Prebiotics
  • Protein Precursors / blood
  • RNA, Ribosomal, 16S / genetics
  • Surveys and Questionnaires
  • Young Adult

Substances

  • Acute-Phase Proteins
  • Calcium, Dietary
  • Carrier Proteins
  • Dietary Fiber
  • Fatty Acids, Volatile
  • Haptoglobins
  • Insulin
  • Membrane Glycoproteins
  • Prebiotics
  • Protein Precursors
  • RNA, Ribosomal, 16S
  • lipopolysaccharide-binding protein
  • zonulin